Growth for both business areas and strong fin...

Sales up, but profits and margins are slipping—Hungary project adds risk, not relief.

What the company is saying

Nolato AB is presenting itself as a company with steady sales growth and operational progress, particularly highlighting the start of commercial production in Hungary. The core narrative is that the business is expanding capacity and delivering on previously communicated projects, with management emphasizing that both main business areas—Medical Solutions and Engineered Solutions—are contributing to consolidated sales growth. The company claims a 'sustained strong financial position' that enables flexibility, though this is not backed by specific numbers. The announcement puts front and center the increase in sales (SEK 2,454 million for Q2 2026) and the operational milestone in Hungary, while downplaying the decline in profitability and margins. The language is measured and factual, with a neutral tone and little promotional flair, but it does use broad statements like 'organic growth' and 'strong financial position' without detailed substantiation. Christer Wahlquist, President and CEO, and Per-Ola Holmström, CFO, are named as key executives, signaling that the communication is coming from the top and intended to reassure investors about leadership oversight. Their involvement is standard for a quarterly report and does not, in itself, signal any unusual institutional commitment or external validation. The messaging fits a classic investor relations approach: highlight operational wins and sales growth, acknowledge but minimize negatives, and project confidence in ongoing projects and financial stability.

What the data suggests

The numbers show that while Nolato AB achieved a modest increase in sales—SEK 2,454 million in Q2 2026 versus SEK 2,395 million previously—profitability is under pressure. Operating profit (EBITA) dropped to SEK 247 million from SEK 277 million, and the EBITA margin fell to 10.1% from 11.6%, indicating that costs are rising faster than revenues or that pricing power is weakening. Profit after tax declined to SEK 169 million from SEK 212 million, and earnings per share slipped to SEK 0.63 from SEK 0.79, both clear signs of deteriorating bottom-line performance. For the first half of 2026, group sales were SEK 4,811 million, slightly down from SEK 4,848 million, and operating profit (EBITA) was SEK 507 million, down from SEK 548 million, with the EBITA margin also lower at 10.5% versus 11.3%. Cash flow from operating activities was SEK 287 million in Q2 (down from SEK 316 million), but for the half-year, it improved to SEK 512 million from SEK 451 million, suggesting some improvement in working capital or collections. Net financial liabilities increased marginally to SEK 1,055 million from SEK 1,038 million, which is not alarming but does not support the claim of a 'sustained strong financial position' without further context. The data is generally clear and allows for direct period-over-period comparison, but key qualitative claims—such as organic growth by business area and financial flexibility—are not quantified. An independent analyst would conclude that the company is facing margin compression and that operational progress in Hungary has yet to translate into improved profitability.

Analysis

The announcement is largely factual, with the majority of claims supported by realised financial and operational data for the second quarter and first half of 2026. The only forward-looking statement concerns the gradual installation and fine-tuning of additional capacity, which is a logical next step following the commencement of commercial production in Hungary. While the tone is generally neutral and avoids promotional language, there is a minor gap between narrative and evidence in the assertion of a 'sustained strong financial position,' which is not directly quantified. The capital intensity flag is set because the Hungary project involves ongoing capacity expansion, but the benefits are not immediate and will accrue over time. However, the overall hype level is minimal, as the report is transparent about declining profitability and does not overstate future prospects.

Risk flags

• ●Profitability is declining despite higher sales, with EBITA margin dropping from 11.6% to 10.1% in Q2 2026. This signals that cost pressures or pricing challenges are eroding the company's ability to convert sales into profit, which is a red flag for future earnings quality.
• ●The Hungary project is capital intensive and still in the early stages of commercial production, with further capacity installation and fine-tuning required. This exposes the company to execution risk, including delays, cost overruns, or operational setbacks that could impact both cash flow and profitability.
• ●The claim of a 'sustained strong financial position' is not supported by specific metrics or definitions. Without clear evidence, investors cannot assess the company's true financial flexibility or resilience to shocks.
• ●Key qualitative claims, such as organic growth by business area, are not backed by granular data. This lack of transparency makes it difficult for investors to evaluate the underlying health and drivers of each segment.
• ●Net financial liabilities have increased slightly, and while not yet alarming, any further rise—especially in the context of declining profitability—could constrain future investment or dividend capacity.
• ●The majority of positive claims about future delivery capacity are forward-looking and contingent on successful project execution in Hungary. If these milestones are delayed or missed, the anticipated benefits may not materialize within a reasonable investment horizon.
• ●Cash flow from operating activities declined in the second quarter (SEK 287 million vs. SEK 316 million), which, if it continues, could pressure liquidity and limit the company's ability to fund ongoing projects without additional borrowing.
• ●No specific customer names or contract values are disclosed for the Hungary project, increasing uncertainty about the scale and reliability of future revenues from this initiative.

Bottom line

For investors, this announcement is a mixed bag: sales are up, but profits and margins are down, and the company's main operational highlight—the Hungary project—remains a work in progress with no immediate financial payoff. The narrative of operational progress and financial strength is only partially credible, as the numbers show clear margin compression and declining profitability. The involvement of the CEO and CFO is standard for a quarterly report and does not signal any special institutional backing or external validation. To improve confidence, the company would need to provide more granular data on organic growth by business area, a clear definition and quantification of its 'strong financial position,' and specific timelines and milestones for the Hungary project. Key metrics to watch in the next reporting period include EBITA margin, cash flow from operations, net financial liabilities, and any concrete updates on Hungary's capacity ramp-up and customer contracts. This announcement is worth monitoring, but not acting on, until there is evidence that operational investments are translating into improved profitability and cash flow. The single most important takeaway is that while Nolato is growing sales and investing in new capacity, its ability to convert that into sustainable profit is under real pressure—and the Hungary project adds execution risk rather than immediate relief.

Announcement summary

(LSE/AIM:0OA9) Nolato AB reported that sales increased to SEK 2,454 million (2,395) in the second quarter of 2026. Production of commercial volumes in the previously communicated customer project in Hungary began at the end of the quarter. Operating profit (EBITA) was SEK 247 million (277), with an EBITA margin of 10.1% (11.6). Profit after tax was SEK 169 million (212), and earnings per share, basic and diluted, totaled SEK 0.63 (0.79). Cash flow from operating activities amounted to SEK 287 million (316). Group sales for the first six months of 2026 totaled SEK 4,811 million (4,848), with an operating profit (EBITA) of SEK 507 million (548). The company projects that additional capacity will be installed and fine-tuned with a view to gradually increasing delivery capacity in line with the communicated schedule.

Disagree with this article?